Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: A drastic improvement in brain perfusion by antiplatelet therapy

European Radiology

Volumn 11, Issue 12, 2001, Pages 2611-2615

  Tokumaru, S ^a   Yoshikai, T ^a   Uchino, A ^a   Matsui, M ^a   Kuroda, Y ^a   Kudo, S ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Antiphospholipid antibody syndrome; Antiplatelet therapy; MR imaging; SPECT; Tc 99m ECD

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYSTEINE ETHYL ESTER TC 99M;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CASE REPORT; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; CEREBRAL INFARCTION; CYSTEINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0035203220     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300100841     Document Type: Article

References (18)

1. Anti-phospholipid antibodies
2. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders
3. The "primary" antiphospholipid antibody syndrome: Major clinical and serologic features
4. Neurological aspects of anti-phospholipid antibody syndrome
5. Antiphospholipid antibodies in patients without systemic lupus erythematosus: Neuroradiologic findings
6. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
7. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging. Part 1. Pharmacology of technetium-99m-ECD in nonhuman primates
8. Technetium-99m-ECD: A new brain imaging agent: In vivo kinetics and biodistribution studies in normal human subjects
9. Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects
10. Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder
11. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies
12. Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies
13. Protein C pathway, antiphospholipid antibodies and thrombosis
14. Functional and immunochemical heterogeneity of antiphospholipid antibodies: A classification
15. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies
16. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia
17. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus
18. Positron emission tomography (PET) in Systemic lupus erythematosus: Relation of cerebral vasculitis to PET findings